NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
84.4%
Industry median - 64.9%
5Y Historical average - 86.8%
35.9%
Industry median - (879.7%)
5Y Historical average - 42.0%
24.4%
Industry median - (720.0%)
5Y Historical average - 30.9%
72.6%
Industry median - 83.4%
5Y Historical average - 83.7%
REGN Profitability Rating
Crunching data... Almost there!
REGN Profitability Metrics
Crunching data... Almost there!
Competing with REGN Profitability
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Regeneron Pharmaceuticals, Inc. (REGN) gross profit margin?
The Regeneron Pharmaceuticals, Inc. (REGN) gross profit margin is 84.4%, compared to the industry median of 64.9% and the 5-year historical average of 86.8%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) operating income margin?
The Regeneron Pharmaceuticals, Inc. (REGN) operating income margin is 35.9%, compared to the industry median of (879.7%)) and the 5-year historical average of 42.0%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow (FCF) margin?
The Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow margin is 24.4%, compared to the industry median of (720.0%) and the 5-year historical average of 30.9%.
What is the Regeneron Pharmaceuticals, Inc. (REGN) earnings quality?
The Regeneron Pharmaceuticals, Inc. (REGN) earnings quality is 72.6%, compared to the industry median of 83.4% and the 5-year historical average of 83.7%.